Short Term Efficacy and Safety of Insulin Glargine in Type 2 Diabetes Inadequately Controlled with Single or Two Oral Agents: A Prospective, Open Label Study.

about

Short Term Efficacy and Safety of Insulin Glargine in Type 2 Diabetes Inadequately Controlled with Single or Two Oral Agents: A Prospective, Open Label Study.

Item

http://www.wikidata.org/entity/Q47137775

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Short Term Efficacy and Safety ...... Prospective, Open Label Study.

@en

Short Term Efficacy and Safety ...... Prospective, Open Label Study.

@nl

type

Item

label

Short Term Efficacy and Safety ...... Prospective, Open Label Study.

@en

Short Term Efficacy and Safety ...... Prospective, Open Label Study.

@nl

prefLabel

Short Term Efficacy and Safety ...... Prospective, Open Label Study.

@en

Short Term Efficacy and Safety ...... Prospective, Open Label Study.

@nl

P1476

Short Term Efficacy and Safety ...... Prospective, Open Label Study.

@en

P2093

Ajay Aggarwal

http://www.w3.org/2001/XMLSchema#string

Roopak Wadhwa

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

10-year follow-up of intensive glucose control in type 2 diabetes

Long-term insulin glargine therapy in type 2 diabetes mellitus: a focus on cardiovascular outcomes.

Effect of switching medically vulnerable patients with uncontrolled diabetes from isophane insulin human to insulin glargine.

Socio-economic burden of diabetes in India.

Update on insulin therapy for type 2 diabetes

Age-specific effectiveness and safety of newly initiated insulin therapy in Japanese patients with uncontrolled diabetes.

Epidemiology of type 2 diabetes: Indian scenario.

Effects of basal insulin analog and metformin on glycaemia control and weight as risk factors for endothelial dysfunction.

Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes.

P304

OC21-OC24

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P921

type-2 diabetes

P932

5583854

http://www.w3.org/2001/XMLSchema#string